Tarsus Pharmaceuticals (TARS) Treasury Shares (2021 - 2026)

Tarsus Pharmaceuticals' Treasury Shares history runs 6 years deep, the most recent figure standing at $721325.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 62.65% year-over-year to $721325.0; the TTM figure through Mar 2026 stood at $721325.0 (down 62.65% YoY), while the FY2025 annual figure was $1.8 million, down 8.3% from the prior year.
• Treasury Shares was $721325.0 for Q1 2026 at Tarsus Pharmaceuticals, down from $1.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.0 million in Q1 2024 to a low of $551258.0 in Q4 2022.
• Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.7 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares soared 3095.51% in 2022, then tumbled 62.65% in 2026.
• A 5-year view of Treasury Shares shows it stood at $551258.0 in 2022, then soared by 209.97% to $1.7 million in 2023, then rose by 12.09% to $1.9 million in 2024, then slipped by 8.3% to $1.8 million in 2025, then slumped by 58.93% to $721325.0 in 2026.
• The last three Treasury Shares figures came in at $721325.0 (Q1 2026), $1.8 million (Q4 2025), and $714806.0 (Q3 2025), per Business Quant data.